AKTS · Aktis Oncology, Inc. · Executive Compensation
$18.15
+0.41 (+2.31%)
At close · Oct 9
Return incl. dividend (before tax)
Market Cap
$986.69M
Shares
55.62M
Volume · Oct 9
361.04K
Avg daily vol (3M)
366.04K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Helen S. Kim | member of the Board and all committees thereof | Resigned | 2026-04-16 |
| Oleg Nodelman | member of the Board and all committees thereof | Resigned | 2026-04-16 |
| Glenn Gormley | Class I director | Appointed | 2026-04-16 |